Stay updated on TRuE AD1 Clinical Trial
Sign up to get notified when there's something new on the TRuE AD1 Clinical Trial page.

Latest updates to the TRuE AD1 Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial page now presents the completed NCT03745638 study record, with details about ruxolitinib treatment, study design and outcomes, participant eligibility, locations, and supporting publications and documents.SummaryDifference100%

- Check11 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe 403 error page now displays an NIH notice about terminology changes during its website transition, and the site revision advances to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe ClinicalTrials.gov site footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedStudy record page now displays a 403 Forbidden error, replacing the previously visible study details and related content. This blocks access to the trial's core information including objectives, eligibility criteria, and locations.SummaryDifference21%

- Check60 days agoChange DetectedThe revision tag on the page has been updated to v3.7.0, replacing the previous v3.6.6. This denotes a newer documentation version but does not change the study details or data.SummaryDifference0.0%

Stay in the know with updates to TRuE AD1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRuE AD1 Clinical Trial page.